🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07448090
Recruiting Observational

Real-World Case Registry Study on Obesity

NCT07448090 · tracked via the Priya Life Science China tracker
Sponsor
Hubei Hospital of Traditional Chinese Medicine
Phase
Observational
Started
2024-08-31
Last updated
2026-06-12

Condition(s) studied

Obesity & OverweightObesity (Disorder)

Study summary

Obesity is a major risk factor for cardiovascular disease, diabetes, cancer, and other chronic conditions. Due to its complex etiology and frequent comorbidities, effective obesity management requires comprehensive and individualized approaches. This study is a multicenter, prospective, real-world registry designed to evaluate integrated traditional Chinese medicine (TCM) and Western medicine interventions for obesity.

The study will enroll at least 10,000 individuals with obesity from urban and rural populations. Multimodal data, including electronic medical records, laboratory test results, imaging data, and lifestyle information, will be collected. The effectiveness of integrated TCM and Western medicine interventions will be assessed across different age groups, disease stages, and obesity-related constitution types. In addition, disease progression patterns and key prevention and treatment points will be explored. Health economic analyses will be conducted to evaluate the cost-effectiveness of different obesity management strategies, providing real-world evidence to support public health policy and the optimization of integrated obesity prevention and management approaches.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: 1. Age 18 years and above, gender not restricted; 2. Weight fluctuation within the last 3 months is ≤ 5% and BMI is ≥ 28.0 kg/m2; 3. Good compliance, willing to follow the follow-up principles; 4. Agree to sign the informed consent form. Exclusion Criteria: 1. Co-existing severe diseases of the heart, liver, lungs, kidneys, brain, blood, neuro-psychiatric system, or other vital organs. 2. Secondary obesity (obesity attributable to another clearly diagnosed disorder, e.g., hypothalamic or pituitary inflammation, tumours or trauma, Cushing's syndrome, hypothyroidism, hypogonadism, polycystic ovary syndrome, etc.). 3. Iatrogenic obesity (obesity resulting from drugs or therapeutic interventions administered for other conditions). 4. Pregnant or lactating women. 5. Subjects whom the investigator deems unsuitable for participation in this study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hubei Provincial Hospital of Traditional Chinese Medicine Wuhan Hubei Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07448090 on ClinicalTrials.gov ↗ ← All trials in China